S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 203 SEK -1.93% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stille AB
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Income from Continuing Operations
kr50.9m
CAGR 3-Years
52%
CAGR 5-Years
16%
CAGR 10-Years
44%
Elekta AB (publ)
STO:EKTA B
Income from Continuing Operations
kr1.3B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Income from Continuing Operations
kr193.3m
CAGR 3-Years
86%
CAGR 5-Years
99%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Income from Continuing Operations
kr150.2m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
17%
Getinge AB
STO:GETI B
Income from Continuing Operations
kr2.4B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Income from Continuing Operations
kr480m
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.8B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
286.89 SEK
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Stille AB's Income from Continuing Operations?
Income from Continuing Operations
50.9m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Income from Continuing Operations amounts to 50.9m SEK.

What is Stille AB's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
44%

Over the last year, the Income from Continuing Operations growth was 90%. The average annual Income from Continuing Operations growth rates for Stille AB have been 52% over the past three years , 16% over the past five years , and 44% over the past ten years .

Back to Top